文献速递血脂与心血管预防冠心病

果糖代谢、心血管代谢风险与冠心病流行

Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease.
PubMed 文献 · Eur Heart J · 2018-01-01

综述指出即使独立于热量摄入,添加糖摄入增加仍与心血管代谢综合征和心血管病风险升高相关,全球糖消费量居高不下;果糖代谢主要由肝脏、小肠和肾脏中的酮己糖激酶(KHK)C亚型启动,缺氧环境可解除组织限制,果糖代谢通过促发系统性病理促进CMS和CVD,并影响预防与治疗策略。

要点

  • 添加糖摄入增加与CMS和CVD风险升高相关,独立于总热量摄入。
  • 果糖代谢由肝脏、小肠和肾脏中的KHK C亚型启动。
  • 缺氧环境可解除果糖代谢的组织限制,影响应激条件下代谢调控。

核心结论

  • 果糖代谢在心血管代谢综合征和心血管病发病中起重要作用,独立于热量摄入。
  • 理解果糖代谢的微环境调控有助于制定预防和治疗策略。

研究设计与样本

  • 综述,总结果糖代谢与CMS、CVD关系的最新进展。

主要发现

  • 添加糖摄入增加与CMS和CVD风险升高相关,独立于热量摄入,全球糖消费量仍高。
  • 果糖代谢由肝脏、小肠和肾脏中的KHK C亚型启动。
  • 缺氧环境可解除果糖代谢的组织限制。
  • 果糖代谢促进系统性病理,协同推动CMS和CVD。

临床怎么用

  • 关注添加糖摄入,尤其果糖成分,作为心血管代谢风险管理的一部分。
  • 认识果糖代谢的组织限制及应激条件下的变化,指导预防措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite strong indications that increased consumption of added sugars correlates with greater risks of developing cardiometabolic syndrome (CMS) and cardiovascular disease (CVD), independent of the caloric intake, the worldwide sugar consumption remains high. In considering the negative health impact of overconsumption of dietary sugars, increased attention is recently being given to the role of the fructose component of high-sugar foods in driving CMS. The primary organs capable of metabolizing fructose include liver, small intestine, and kidneys. In these organs, fructose metabolism is initiated by ketohexokinase (KHK) isoform C of the central fructose-metabolizing enzyme KHK. Emerging data suggest that this tissue restriction of fructose metabolism can be rescinded in oxygen-deprived environments. In this review, we highlight recent progress in understanding how fructose metabolism contributes to the development of major systemic pathologies that cooperatively promote CMS and CVD, reference recent insights into microenvironmental control of fructose metabolism under stress conditions and discuss how this understanding is shaping preventive actions and therapeutic approaches.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Mirtschink P, Jang C, Arany Z, et al. Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease. Eur Heart J. 2018. PMID: 29020416. doi:10.1093/eurheartj/ehx518

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。